The transcriptional programs of iNKT cells

Seminars in Immunology

Volumn 27, Issue 1, 2015, Pages 26-32

  Kim, Edy Y ^a   Lynch, Lydia ^a   Brennan, Patrick J ^a   Cohen, Nadia R ^b   Brenner, Michael B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Global transcriptional profiling; Global transcriptome profiling; NKT cell development; NKT cell subset; PLZF

Indexed keywords

MICRORNA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; EARLY GROWTH RESPONSE FACTOR 2; KRUPPEL LIKE FACTOR; TRANSCRIPTOME;

GENETIC TRANSCRIPTION; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NATURAL KILLER CELL; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; INFLAMMATION; METABOLISM; NATURAL KILLER T CELL;

ANIMALS; EARLY GROWTH RESPONSE PROTEIN 2; HUMANS; INFLAMMATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICRORNAS; NATURAL KILLER T-CELLS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84928640883     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2015.02.005     Document Type: Review

References (62)

1. Cohen N.R., Garg S., Brenner M.B. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol 2009, 102:1-94.
2. Pellicci D.G., Hammond K.J., Uldrich A.P., Baxter A.G., Smyth M.J., Godfrey D.I. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J Exp Med 2002, 195(7):835-844.
3. + stage of thymic ontogeny. Proc Natl Acad Sci U S A 2005, 102(14):5114-5119.
4. Gapin L., Matsuda J.L., Surh C.D., Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol 2001, 2(10):971-978.
5. Cohen N.R., Brennan P.J., Shay T., Watts G.F., Brigl M., Kang J., et al. Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat Immunol 2013, 14(1):90-99.
6. Hu T., Gimferrer I., Simmons A., Wiest D., Alberola-Ila J. The Ras/MAPK pathway is required for generation of iNKT cells. PLoS ONE 2011, 6(5):e19890.
7. Seiler M.P., Mathew R., Liszewski M.K., Spooner C.J., Barr K., Meng F., et al. Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat Immunol 2012, 13(3):264-271.
8. Kovalovsky D., Uche O.U., Eladad S., Hobbs R.M., Yi W., Alonzo E., et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol 2008, 9(9):1055-1064.
9. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008, 29(3):391-403.
10. Kreslavsky T., Savage A.K., Hobbs R., Gounari F., Bronson R., Pereira P., et al. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci U S A 2009, 106(30):12453-12458.
11. Alonzo E.S., Gottschalk R.A., Das J., Egawa T., Hobbs R.M., Pandolfi P.P., et al. Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signaling and Id3. J Immunol 2010, 184(3):1268-1279.
12. Constantinides M.G., McDonald B.D., Verhoef P.A., Bendelac A. A committed precursor to innate lymphoid cells. Nature 2014, 508(7496):397-401.
13. Gleimer M., von Boehmer H., Kreslavsky T. PLZF controls the expression of a limited number of genes essential for NKT cell function. Front Immunol 2012, 3:374.
14. Engel I., Zhao M., Kappes D., Taniuchi I., Kronenberg M. The transcription factor Th-POK negatively regulates Th17 differentiation in Valpha14i NKT cells. Blood 2012, 120(23):4524-4532.
15. Monticelli L.A., Yang Y., Knell J., D'Cruz L.M., Cannarile M.A., Engel I., et al. Transcriptional regulator Id2 controls survival of hepatic NKT cells. Proc Natl Acad Sci U S A 2009, 106(46):19461-19466.
16. Mathew R., Seiler M.P., Scanlon S.T., Mao A.P., Constantinides M.G., Bertozzi-Villa C., et al. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature 2012, 491(7425):618-621.
17. Yuan J., Nguyen C.K., Liu X., Kanellopoulou C., Muljo S.A. Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science 2012, 335(6073):1195-1200.
18. Fedeli M., Napolitano A., Wong M.P., Marcais A., de Lalla C., Colucci F., et al. Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol 2009, 183(4):2506-2512.
19. Zheng Q., Zhou L., Mi Q.S. MicroRNA miR-150 is involved in Valpha14 invariant NKT cell development and function. J Immunol 2012, 188(5):2118-2126.
20. Henao-Mejia J., Williams A., Goff L.A., Staron M., Licona-Limon P., Kaech S.M., et al. The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 2013, 38(5):984-997.
21. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003, 9(5):582-588.
22. Kim E.Y., Battaile J.T., Patel A.C., You Y., Agapov E., Grayson M.H., et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 2008, 14(6):633-640.
23. Hong S., Wilson M.T., Serizawa I., Wu L., Singh N., Naidenko O.V., et al. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001, 7(9):1052-1056.
24. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., Sondhi J., Naidenko O.V., et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001, 7(9):1057-1062.
25. Masuda K., Makino Y., Cui J., Ito T., Tokuhisa T., Takahama Y., et al. Phenotypes and invariant alpha beta TCR expression of peripheral V alpha 14+ NK T cells. J Immunol 1997, 158(5):2076-2082.
26. Johnston B., Kim C.H., Soler D., Emoto M., Butcher E.C. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J Immunol 2003, 171(6):2960-2969.
27. Thomas S.Y., Scanlon S.T., Griewank K.G., Constantinides M.G., Savage A.K., Barr K.A., et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med 2011, 208(6):1179-1188.
28. Ohteki T., Maki C., Koyasu S., Mak T.W., Ohashi P.S. Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways. J Immunol 1999, 162(7):3753-3756.
29. Lynch L., Michelet X., Zhang S., Brennan P.J., Moseman A., Lester C., et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue. Nat Immunol 2015, 16(1):85-95.
30. Liang B., Hara T., Wagatsuma K., Zhang J., Maki K., Miyachi H., et al. Role of hepatocyte-derived IL-7 in maintenance of intrahepatic NKT cells and T cells and development of B cells in fetal liver. J Immunol 2012, 189(9):4444-4450.
31. + NKT cells patrolling liver sinusoids. PLoS Biol 2005, 3(4):e113.
32. Yang Y., Ueno A., Bao M., Wang Z., Im J.S., Porcelli S., et al. Control of NKT cell differentiation by tissue-specific microenvironments. J Immunol 2003, 171(11):5913-5920.
33. Baev D.V., Caielli S., Ronchi F., Coccia M., Facciotti F., Nichols K.E., et al. Impaired SLAM-SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice. J Immunol 2008, 181(2):869-877.
34. Aktan I., Chant A., Borg Z.D., Damby D.E., Leenstra P.C., Lilley G.W., et al. Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function. J Immunol 2010, 185(1):144-156.
35. Jordan M.A., Fletcher J.M., Pellicci D., Baxter A.G. Slamf1: the NKT cell control gene Nkt1. J Immunol 2007, 178(3):1618-1627.
36. Gumperz J.E., Miyake S., Yamamura T., Brenner M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002, 195(5):625-636.
37. Lee P.T., Benlagha K., Teyton L., Bendelac A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med 2002, 195(5):637-641.
38. Watarai H., Sekine-Kondo E., Shigeura T., Motomura Y., Yasuda T., Satoh R., et al. Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol 2012, 10(2):e1001255.
39. Lee Y.J., Holzapfel K.L., Zhu J., Jameson S.C., Hogquist K.A. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat Immunol 2013, 14(11):1146-1154.
40. Constantinides M.G., Bendelac A. Transcriptional regulation of the NKT cell lineage. Curr Opin Immunol 2013, 25(2):161-167.
41. Wei G., Abraham B.J., Yagi R., Jothi R., Cui K., Sharma S., et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 2011, 35(2):299-311.
42. Crowe N.Y., Coquet J.M., Berzins S.P., Kyparissoudis K., Keating R., Pellicci D.G., et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 2005, 202(9):1279-1288.
43. + T cells. Cell 1997, 89(4):587-596.
44. Pai S.Y., Truitt M.L., Ho I.C. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci U S A 2004, 101(7):1993-1998.
45. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007, 204(5):995-1001.
46. Barral P., Eckl-Dorna J., Harwood N.E., De Santo C., Salio M., Illarionov P., et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc Natl Acad Sci U S A 2008, 105(24):8345-8350.
47. Galli G., Nuti S., Tavarini S., Galli-Stampino L., De Lalla C., Casorati G., et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J Exp Med 2003, 197(8):1051-1057.
48. King I.L., Fortier A., Tighe M., Dibble J., Watts G.F., Veerapen N., et al. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat Immunol 2012, 13(1):44-50.
49. Chang P.P., Barral P., Fitch J., Pratama A., Ma C.S., Kallies A., et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat Immunol 2012, 13(1):35-43.
50. + T cells. Nat Immunol 2011, 12(5):450-459.
51. Lynch L., Nowak M., Varghese B., Clark J., Hogan A.E., Toxavidis V., et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 2012, 37(3):574-587.
52. Sag D., Krause P., Hedrick C.C., Kronenberg M., Wingender G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J Clin Invest 2014, 124:3725-3740.
53. Schipper H.S., Rakhshandehroo M., van de Graaf S.F., Venken K., Koppen A., Stienstra R., et al. Natural killer T cells in adipose tissue prevent insulin resistance. J Clin Invest 2012, 122(9):3343-3354.
54. Ji Y., Sun S., Xu A., Bhargava P., Yang L., Lam K.S., et al. Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem 2012, 287(17):13561-13571.
55. Huh J.Y., Kim J.I., Park Y.J., Hwang I.J., Lee Y.S., Sohn J.H., et al. A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol Cell Biol 2013, 33(2):328-339.
56. Daussy C., Faure F., Mayol K., Viel S., Gasteiger G., Charrier E., et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J Exp Med 2014, 211(3):563-577.
57. Novershtern N., Subramanian A., Lawton L.N., Mak R.H., Haining W.N., McConkey M.E., et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 2011, 144(2):296-309.
58. Caielli S., Conforti-Andreoni C., Di Pietro C., Usuelli V., Badami E., Malosio M.L., et al. On/off TLR signaling decides proinflammatory or tolerogenic dendritic cell maturation upon CD1d-mediated interaction with invariant NKT cells. J Immunol 2010, 185(12):7317-7329.
59. Globisch T., Steiner N., Fulle L., Lukacs-Kornek V., Degrandi D., Dresing P., et al. Cytokine-dependent regulation of dendritic cell differentiation in the splenic microenvironment. Eur J Immunol 2014, 44(2):500-510.
60. Lee P.T., Putnam A., Benlagha K., Teyton L., Gottlieb P.A., Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 2002, 110(6):793-800.
61. Crawford G., Enders A., Gileadi U., Stankovic S., Zhang Q., Lambe T., et al. DOCK8 is critical for the survival and function of NKT cells. Blood 2013, 122(12):2052-2061.
62. Harada Y., Tanaka Y., Terasawa M., Pieczyk M., Habiro K., Katakai T., et al. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood 2012, 119(19):4451-4461.